tradmap

TMDX Earnings Transmedics Group, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$2 $2 $5 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $303M $605M 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$44M $73M $190M $0 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 $1 $3 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $87M $174M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Revenue
Net income (quarterly)
-$25M $40M $105M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income

Reported EPS history

1–32 of 32
Q2 20262026-06-300.412026-08-0410-Q
Q1 20262026-03-310.202026-05-0510-Q
Q4 2025 (derived)2025-12-312.592026-02-2410-K
FY 20252025-12-314.872026-02-2410-K
Q3 20252025-09-300.662025-10-2910-Q
Q2 20252025-06-300.922025-07-3010-Q
Q1 20252025-03-310.702025-05-0810-Q
Q4 2024 (derived)2024-12-310.192025-02-2710-K
FY 20242024-12-311.012025-02-2710-K
Q3 20242024-09-300.122024-10-2910-Q
Q2 20242024-06-300.352024-08-0110-Q
Q1 20242024-03-310.352024-05-0210-Q
Q4 2023 (derived)2023-12-310.122024-02-2710-K
FY 20232023-12-31-0.772024-02-2710-K
Q3 20232023-09-30-0.782023-11-0810-Q
Q2 20232023-06-30-0.032023-08-0410-Q
Q1 20232023-03-31-0.082023-05-0410-Q
Q4 2022 (derived)2022-12-31-0.192023-02-2710-K
FY 20222022-12-31-1.232023-02-2710-K
Q3 20222022-09-30-0.252022-11-0410-Q
Q2 20222022-06-30-0.412022-08-0310-Q
Q1 20222022-03-31-0.382022-05-0510-Q
Q4 2021 (derived)2021-12-31-0.452022-03-0110-K
FY 20212021-12-31-1.602022-03-0110-K
Q3 20212021-09-30-0.472021-11-0910-Q
Q2 20212021-06-30-0.392021-08-0610-Q
Q1 20212021-03-31-0.292021-05-0710-Q
Q4 2020 (derived)2020-12-31-0.19——
FY 20202020-12-31-1.16——
Q3 20202020-09-30-0.19——
Q2 20202020-06-30-0.36——
Q1 20202020-03-31-0.42——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.